Home
Storia in 2 fonti
Investors flock to Chinese herbal medicine stock with no revenues - UPI.com
Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues.
- ·
cnbc.com
Nasdaq-traded Chinese herb company hits near $30 billion market value after speculative surge
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 40,000% year to date.
- ·
upi.com
Investors flock to Chinese herbal medicine stock with no revenues - UPI.com
Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues.